The tumor microenvironment (TME) is highly complex and dynamic, shaped by diverse immune and tumor cell interactions. CD markers and immune checkpoints provide complementary insights into these processes, enabling precise characterization and improved strategies for immunotherapy research.
Download this infographic to learn more about targeting CD markers and immune checkpoints in cancer research.















